refining best practices in cancer immunotherapy biomarker testing and pathologic response assessment
Published 1 year ago • 531 plays • Length 1:11:32Download video MP4
Download video MP3
Similar videos
-
1:26:59
progress in immunotherapy biomarker testing and pathologic response assessment in solid tumors
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies
-
1:03:55
the nuances of immunotherapy biomarker testing in solid tumors
-
1:31:16
pathologic response after neoadjuvant immunotherapy: facilitating progress in early-stage cancers
-
1:14:51
the present and the future of cancer immunotherapy biomarkers
-
49:36
pathway to decoding the impact of cancer immunotherapy
-
1:29:21
the central role of biomarker testing in piecing together the immuno-oncology puzzle
-
58:57
navigating the complexities of biomarker testing in the expanding field of precision immuno-oncology
-
1:39:03
everything you need to know about biomarker testing and treatment of genomically altered nsclc
-
1:27:49
biomarker testing for new therapeutic options targeting her2, her3, and trop2 in solid tumors
-
1:33:59
revisiting pd-l1 as an immunotherapy biomarker across the cancer spectrum
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
10:28
candid conversations in lung cancer: discussing biomarker testing and targeted therapies
-
1:01:46
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
1:05:35
drs. cottrell & sholl discuss #immunotherapy updates at #uscap2023 - https://bit.ly/3mkijyk
-
1:07:31
precision decisions in genomic testing and targeted treatment of nsclc
-
59:58
management of esophageal/gej cancers: an interdisciplinary tumor board on adjuvant immunotherapy
-
26:32
standard and alternative dosing regimens of immunotherapies and combinations in modern oncology
-
1:14:14
fine-tuning biomarker testing to identify and target ret fusions in nsclc